If you look at the two exhibits that accompany the
Post# of 36537
(Total Views: 386)
Posted On: 07/17/2019 12:28:11 AM
If you look at the two exhibits that accompany the 8K, you’ll see in After Closing:
MediSource
“if Seller increases the EBITDA related to the Business from the One Hundred Thirty Thousand Dollars ($130,000.00) in EBITDA in 2018...”
Pantheon
“ if Seller increases the EBITDA related to the Business from Five Hundred Thousand Dollars ($500,000.00) in EBITDA in 2018”
So these two companies only had a combined EBITDA of $630,000 in 2018. I’m not understanding how with such a small EBITDA they can pay Mr Bird any royalty on sales. But, there’s a CC to learn more.
https://www.sec.gov/Archives/edgar/data/10597...-index.htm
MediSource
“if Seller increases the EBITDA related to the Business from the One Hundred Thirty Thousand Dollars ($130,000.00) in EBITDA in 2018...”
Pantheon
“ if Seller increases the EBITDA related to the Business from Five Hundred Thousand Dollars ($500,000.00) in EBITDA in 2018”
So these two companies only had a combined EBITDA of $630,000 in 2018. I’m not understanding how with such a small EBITDA they can pay Mr Bird any royalty on sales. But, there’s a CC to learn more.
https://www.sec.gov/Archives/edgar/data/10597...-index.htm
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼